2005
DOI: 10.1016/j.jaci.2004.11.040
|View full text |Cite
|
Sign up to set email alerts
|

Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
26
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 61 publications
(29 citation statements)
references
References 25 publications
3
26
0
Order By: Relevance
“…The indication of a more antigen presentation phenotype of the macrophages (elevated level of CD86)22 in the present study resemble patterns observed after LPS inhalation challenge 8. After 6 h of inhaled LPS, markers of dendritic cell maturation were upregulated and discrete populations of mature dendritic cell were observed.…”
Section: Discussionsupporting
confidence: 83%
See 3 more Smart Citations
“…The indication of a more antigen presentation phenotype of the macrophages (elevated level of CD86)22 in the present study resemble patterns observed after LPS inhalation challenge 8. After 6 h of inhaled LPS, markers of dendritic cell maturation were upregulated and discrete populations of mature dendritic cell were observed.…”
Section: Discussionsupporting
confidence: 83%
“…Studies involving LPS challenge in healthy volunteers and in vitro exposure to organic dust have shown that the cell surface phenotypes on airway cells have been modified 7 8. Cell surface phenotypes, such as the Fcγ receptors CD16/FcγRIII and CD64/FcγRI, are involved in neutrophil activation and are upregulated in proinflammatory environments 9.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…All volunteers had normal lung function, normal methacholine challenge and negative skin tests and were genotyped only after challenge and assessment of samples was completed, thus avoiding selection bias. Venipuncture, induced sputum, spirometry, cytokine measurements in sputum and genotyping for GSTM1 were performed as previously described 8 9. Circulating total WBCs, PMNs and platelet counts, sputum PMNs and mediators in recovered sputum samples, spirometry measures and symptom scores were assessed at baseline (pre-challenge) and 4 h after CCRE challenge was complete in GSTM1 null and sufficient cohorts.…”
Section: Methodsmentioning
confidence: 99%